VERU INC. Income Tax Examination, Penalties and Interest Expense
VERU INC. (VERU) reported Income Tax Examination, Penalties and Interest Expense of $0 for the 12-month period ending 2022-09-30, per its 10-K filed 2022-12-05.
Discontinued › Expense Statement › Interest Expense
us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense · last filed 2022-12-05
- VERU INC. income tax examination, penalties and interest expense for fiscal 2022 was $0.00.
- VERU INC. income tax examination, penalties and interest expense for fiscal 2021 was $0.00.
- VERU INC. income tax examination, penalties and interest expense for fiscal 2020 was $0.00.
- VERU INC. income tax examination, penalties and interest expense for fiscal 2019 was $0.00.
| Period end | Income Tax Examination, Penalties and Interest Expense 12 month |
|---|---|
| 2022-09-30 | $0.00 10-K · filed 2022-12-05 |
| 2021-09-30 | $0.00 10-K · filed 2022-12-05 |
| 2020-09-30 | $0.00 10-K · filed 2021-12-02 |
| 2019-09-30 | $0.00 10-K · filed 2020-12-10 |
| 2018-09-30 | $0.00 10-K · filed 2019-12-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |